Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 3/20 | 0.48 |
| ▸ | MMP9 | P14780 | 3/20 | 0.48 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TACR2 | P21452 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21973419 | 0.81 | SMN1; SMN2 (0.39) | MMP1MMP9MMP3CYP2D6SMN1; SMN2 | |
| SCHEMBL20734813 | 0.80 | ALDH1A1 (0.41) | MMP1MMP9MMP3CYP2D6SMN1; SMN2 | |
| SCHEMBL20734875 | 0.80 | ALDH1A1 (0.41) | MMP1MMP9MMP3CYP2D6SMN1; SMN2 | |
| SCHEMBL684696 | 0.77 | SAE1 (0.59) | SMN1; SMN2LMNAALDH1A1KMT2AKDM4E | |
| SCHEMBL15672146 | 0.77 | LMNA (0.40) | LMNAALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL9402139 | 0.77 | NPSR1 (0.51) | MMP1MMP9MMP3SMN1; SMN2LMNA | |
| SCHEMBL1871227 | 0.77 | LMNA (0.67) | SMN1; SMN2LMNAALDH1A1MAPK1MEN1 | |
| SCHEMBL155983 | 0.77 | LMNA (0.67) | SMN1; SMN2LMNAALDH1A1MAPK1MEN1 | |
| SCHEMBL10466629 | 0.75 | MMP1 (0.44) | MMP1MMP9MMP3GLANPSR1 | |
| Cesium SCHEMBL5969740 | 0.75 | LMNA (0.64) | SMN1; SMN2LMNAALDH1A1MAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8883861-B2 | Iminic monomers and polymers thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-11-11 | — | — | US | disclosed |
| US-20120108677-A1 | IMINIC MONOMERS AND POLYMERS THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108677-A1 | IMINIC MONOMERS AND POLYMERS THEREOF | MIF, IGF2BP1, INMT | MMP1 233/4885MMP9 727/4885MMP3 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.